| Cleveland Emergency Hospital | |
| 1017 S Travis Ave, Cleveland, Texas 77327 | |
| (281) 592-5400 | |
| Not Available |
| Name | Cleveland Emergency Hospital |
|---|---|
| Type | Acute Care Hospital |
| Location | 1017 S Travis Ave, Cleveland, Texas |
| Ownership | Proprietary |
| Emergency Services | Yes |
| Medicare ID (CCN) | 670115 |
| NPI Number | 1972540532 |
| Organization Name | CLEVELAND IMAGING AND SURGICAL HOSPITAL, L.L.C. |
| Doing Business As | DOCTOR'S DIAGNOSTIC HOSPITAL |
| Address | 1017 S Travis Ave, Cleveland, TX 77327 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 281-622-2900 |
News Archive
Researchers from the University of Sydney's Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders have developed a portable and easy-to-use method to help people estimate portion size using only their hands.
Scientists are beginning to unwrap the biology behind why some people are more prone to major depression and other psychiatric disorders than others when experiencing stressful life events. The researchers found that cellular activity in response to stress hormone receptor activation differs from individual to individual.
A new study in the Journal of Sexual Medicine found that the presence of depressive symptoms in men with erectile dysfunction constitutes a risk factor for a major cardiovascular event.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.
› Verified 3 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Researchers from the University of Sydney's Boden Institute of Obesity, Nutrition, Exercise & Eating Disorders have developed a portable and easy-to-use method to help people estimate portion size using only their hands.
Scientists are beginning to unwrap the biology behind why some people are more prone to major depression and other psychiatric disorders than others when experiencing stressful life events. The researchers found that cellular activity in response to stress hormone receptor activation differs from individual to individual.
A new study in the Journal of Sexual Medicine found that the presence of depressive symptoms in men with erectile dysfunction constitutes a risk factor for a major cardiovascular event.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.
› Verified 3 days ago
Cleveland Emergency Hospital Acute Care Hospital Location: 1017 S Travis Ave, Cleveland, Texas 77327 Phone: (281) 592-5400 |